MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

30 Oct 2023 Evaluate
The September 2023 quarter revenue stood at Rs. 115.28 millions, up 12.03% as compared to Rs. 102.90 millions during the corresponding quarter last year.Net profit for the quarter ended September 2023 increases to Rs. 28.33  millions from Rs. 27.66 millions.Operating profit surged to 57.04 millions from the corresponding previous quarter of 56.55 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 115.28 102.90 12.03 207.84 226.56 -8.26 424.24 365.65 16.02
Other Income 1.93 6.47 -70.17 3.94 6.95 -43.31 10.84 6.29 72.34
PBIDT 57.04 56.55 0.87 95.71 127.92 -25.18 217.87 180.90 20.44
Interest 0.00 0.00 0.00 0.00 1.12 0.00 1.12 12.15 -90.78
PBDT 57.04 56.55 0.87 95.71 126.80 -24.52 216.75 168.75 28.44
Depreciation 18.07 18.05 0.11 36.08 35.91 0.47 71.73 69.74 2.85
PBT 38.97 38.50 1.22 59.63 90.89 -34.39 145.02 99.01 46.47
TAX 10.64 10.84 -1.85 16.86 25.52 -33.93 29.17 -122.75 -123.76
Deferred Tax 10.64 10.84 -1.85 16.86 25.52 -33.93 29.17 -122.75 -123.76
PAT 28.33 27.66 2.42 42.77 65.37 -34.57 115.85 221.76 -47.76
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 49.48 54.96 -9.97 46.05 56.46 -18.44 51.36 49.47 3.80
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..